Difference between revisions of "Talk:Main Page"
(I'm in my first year at university http://www.euniceproductions.com/pixelmaniacs/ dapoxetine hci The 8.9-inch Kindle Fire HDX starts at $379 for 8 GB of memory, while the 7-inch starts at $229 also w) |
(We went to university together http://www.whitneymartindesign.com/how-to-write-research-papers/ buy comparison/contrast essay This is the wrong question, and falls straight into the government's trap) |
||
| Line 1: | Line 1: | ||
| − | + | We went to university together http://www.whitneymartindesign.com/how-to-write-research-papers/ buy comparison/contrast essay This is the wrong question, and falls straight into the government's trap. Their position is that the NHS is unsustainable, that "we can't carry on like this". But those who have watched the NHS brought to its knees by the coalition have questions to ask, and some solutions to propose that do not involve cuts or payments for service. For that is surely where this government wants this conversation to end up: the NHS is unsustainable. This is a convenient myth to explain the next myth, that "things can't go on like this". The fact is that it is not a given that changing demographics and new drugs necessarily lead to accelerated costs. We must challenge the myths and the figures. | |
Revision as of 06:33, 15 August 2014
We went to university together http://www.whitneymartindesign.com/how-to-write-research-papers/ buy comparison/contrast essay This is the wrong question, and falls straight into the government's trap. Their position is that the NHS is unsustainable, that "we can't carry on like this". But those who have watched the NHS brought to its knees by the coalition have questions to ask, and some solutions to propose that do not involve cuts or payments for service. For that is surely where this government wants this conversation to end up: the NHS is unsustainable. This is a convenient myth to explain the next myth, that "things can't go on like this". The fact is that it is not a given that changing demographics and new drugs necessarily lead to accelerated costs. We must challenge the myths and the figures.